Fernandez, Baby Boy .

HRN: 23-76-49  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
AMPICILLIN 250MG (VIAL)
10/17/2023
10/23/2023
IVT
145mg
Q12hrs
Thickly Msaf
Waiting Final Action 
10/17/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
10/17/2023
10/23/2023
IVY
15mg
OD
Thickly Msaf
Waiting Final Action 
10/26/2023
CEFOTAXIME 500MG (VIAL)
10/26/2023
11/04/2023
IV
145mg
Q12h
Potentially Septic Newborn
Checking Final Appropriateness 
10/26/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/26/2023
11/01/2023
IV
40mg
OD
Potentially Septic Newborn
Checking Final Appropriateness 
10/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/28/2023
11/04/2023
IV
40mg
Q8h
Potentially Septic Newborn (Thickly Msaf)
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: